We are delighted to announce that OBH will continue working in partnership with Guy’s and St Thomas’ (GSTT) Charity and King’s College London (KCL) on a programme of work focussed around understanding and slowing the progression to multiple long-term conditions.
The first stage of the project involved defining a list of 32 long-term conditions and six risk factors through a rigorous consultation method with patient representatives, partners from the NHS, local government and the voluntary sector. Both national and international definitions of long-term conditions were analysed, amongst other criteria including the impact of long-term conditions on people’s lives, treatment burden, age of onset and likelihood of progression to further long-term conditions, amongst others.
The next stage will continue to explore multiple long-term conditions, including factors like the impact of deprivation in people’s journey and the role of key life events as potential windows for early intervention. We look forward to continue working in partnership with GSTT Charity and KCL on this exciting and important project!
Read more about the project here.
We are very excited to announce that OBH has been selected to participate in the Health Data Research UK Sandbox!
The initial phase of the programme will involve the use of linked, longitudinal health data to measure and validate OBH’s HEALTHSPAN and HEALTHY LIFESPAN index measures.
Health Data Research UK is the national institute for health data science with a mission to align the UK’s health data to enable discoveries that improve people’s lives. The Health Data Research UK Sandbox is a virtual testing environment for products, services, innovations or knowledge that require access to large scale data to improve the health of patients and the population. The Sandbox will provide test cases for a government initiative, delivered by Health Data Research UK, to transform access to the UK’s health data – safely and securely – for research that could pioneer new and faster treatments for patients and find new cures for diseases.
We are delighted to have been selected and look forward to being involved in this exciting programme!